Page last updated: 2024-08-21

thiazoles and Leukemia, Myelomonocytic, Chronic

thiazoles has been researched along with Leukemia, Myelomonocytic, Chronic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kiriyama, Y; Nochi, H; Sakurada, Y; Sugimura, A; Tamoto, K; Tokumitsu, Y; Tsuchiya, H; Ui, M	1

Other Studies

1 other study(ies) available for thiazoles and Leukemia, Myelomonocytic, Chronic

Article	Year
Troglitazone suppresses cell growth of myeloid leukemia cell lines by induction of p21WAF1/CIP1 cyclin-dependent kinase inhibitor. Biochemical and biophysical research communications, 1999, Aug-11, Volume: 261, Issue:3 Topics: Antineoplastic Agents; Cell Cycle; Cell Division; Chromans; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA; Enzyme Inhibitors; Flow Cytometry; Gene Expression; Humans; Hypereosinophilic Syndrome; Leukemia, Myeloid; Leukemia, Myelomonocytic, Acute; Leukemia, Myelomonocytic, Chronic; RNA, Messenger; Thiazoles; Thiazolidinediones; Troglitazone; Tumor Cells, Cultured	1999

Article

Year

Troglitazone suppresses cell growth of myeloid leukemia cell lines by induction of p21WAF1/CIP1 cyclin-dependent kinase inhibitor.

Biochemical and biophysical research communications, 1999, Aug-11, Volume: 261, Issue:3

Topics: Antineoplastic Agents; Cell Cycle; Cell Division; Chromans; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA; Enzyme Inhibitors; Flow Cytometry; Gene Expression; Humans; Hypereosinophilic Syndrome; Leukemia, Myeloid; Leukemia, Myelomonocytic, Acute; Leukemia, Myelomonocytic, Chronic; RNA, Messenger; Thiazoles; Thiazolidinediones; Troglitazone; Tumor Cells, Cultured

1999